Atherosclerosis

Clinical Trial Finder

Many patients with atherosclerosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

Condition:   Atherosclerosis
Interventions:   Drug: rivaroxaban;   Drug: Warfarin
Sponsor:   Los Angeles Biomedical Research Institute
Recruiting - verified February 2015

Pd/Pa vs iFR in an Unselected Population Referred for Invasive Angiography

Conditions:   Coronary Artery Disease;   Plaque;   Atherosclerosis;   Coronary Physiology
Intervention:  
Sponsor:   Golden Jubilee National Hospital
Recruiting - verified February 2015

Bile Acids and Gut Microbiota as Potent Coronary Atheroma Risk Factors: a Prospective Study in Human

Condition:   Coronary Disease
Interventions:   Other: No intervention;   Other: Healthy subject
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2015

Exparel as a Nerve Block for Severe Hand Pain

Conditions:   CREST Syndrome;   Peripheral Vascular Disease;   Raynaud Disease;   Scleroderma, Diffuse
Intervention:   Drug: liposomal bupivacaine
Sponsor:   Jose Soberon, MD
Recruiting - verified February 2015

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Condition:   Ischemic Heart Disease
Interventions:   Drug: GS-6615;   Drug: Placebo
Sponsor:   Gilead Sciences
Not yet recruiting - verified February 2015

Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy

Condition:   Cardiac Allograft Vasculopathy
Intervention:   Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
Sponsor:   Universita di Verona
Recruiting - verified February 2015

Lowering Blood Pressure in Primary Care in Vienna

Condition:   Hypertension
Intervention:   Drug: Olmesartan medoxomil, amlodipine, hydrochlorothiazide
Sponsors:   Wilhelminenspital Vienna;   Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology ;   Ludwig Boltzmann Foundation for Cardiovascular Research
Not yet recruiting - verified February 2015

Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)

Condition:   Peripheral Artery Disease With Intermittent Claudication
Interventions:   Drug: Olmesartan;   Drug: other anti-hypertensive drug
Sponsor:   Yonsei University
Recruiting - verified February 2015

Regional Activation of Leukocytes in Coronary Artery Disease

Conditions:   Inflammation;   Coronary Artery Disease
Intervention:  
Sponsor:   Sint Franciscus Gasthuis
Completed - verified February 2015

Cilostazol After Lower Extremity Arterial Revascularization Trial

Conditions:   Peripheral Arterial Disease;   Claudication (Finding)
Intervention:   Drug: Cilostazol
Sponsor:   Wake Forest School of Medicine 
Not yet recruiting - verified February 2015

Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System

Condition:   Peripheral Vascular Disease
Intervention:   Device: Magellan Robotic 6 Fr Catheter
Sponsor:   Hansen Medical
Recruiting - verified February 2015

Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke

Condition:   Carotid Artery Plaque
Intervention:  
Sponsors:   University Hospital Ostrava;   General Teaching Hospital, Prague;   Charles University, Czech Republic;   Palacky University
Not yet recruiting - verified March 2015

Predictive Factors for Anastomotic Leakage After Colorectal Surgery

Conditions:   Anastomotic Leakage;   Colorectal Cancer;   Anastomotic Leak;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Tumors
Intervention:   Other: No interventions, only data collection
Sponsors:   Maastricht University Medical Center;   CMTC Research;   Maxima Medical Center;   Orbis Medical Centre;   Atrium Medical Center
Not yet recruiting - verified February 2015

Physical and Functional Recovery From Cardiac Surgery in Hospitalized Patients: A Feasibility Pilot Study

Conditions:   Coronary Artery Disease;   Mitral Valve Insufficiency;   Aortic Valve Stenosis;   Aortic Valve Regurgitation;   Mitral Valve Stenosis;   Coronary Artery Bypass Graft Triple Vessel
Intervention:   Procedure: Ambulation orderly
Sponsors:   Baystate Medical Center;   Springfield College
Not yet recruiting - verified February 2015

Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting

Condition:   Coronary Artery Disease
Intervention:   Other: Sonolysis
Sponsor:   University Hospital Ostrava
Not yet recruiting - verified March 2015

BIOLUX P-III All-Comers Passeo-18 Lux Registry

Conditions:   Atherosclerosis;   Peripheral Artery Disease
Intervention:   Device: Passeo-18 Lux
Sponsor:   Biotronik AG
Recruiting - verified March 2015

Radial Artery Clamp Times in Patients Undergoing Cardiac Catheterization Via Transradial Approach

Condition:   Coronary Artery Disease
Interventions:   Device: Vascular compression device- RADAR TM-Short clamp time;   Device: Vascular compression device RADAR TM-Long clamp time
Sponsor:   Lawson Health Research Institute
Recruiting - verified March 2015

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Condition:   Hyperlipidemia
Interventions:   Drug: Evacetrapib;   Drug: Atorvastatin;   Drug: Ezetimibe;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2015

Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program

Conditions:   Coronary Artery Disease;   Myocardial Infarction
Interventions:   Other: Interval exercise training;   Other: Continuous exercise training
Sponsor:   Assaf-Harofeh Medical Center
Recruiting - verified February 2015

Carnitine for the Treatment of Atherosclerosis.

Condition:   Metabolic Syndrome
Interventions:   Dietary Supplement: L-carnitine capsules;   Dietary Supplement: Lactose capsules
Sponsors:   Queen's University;   Heart and Stroke Foundation of Canada
Recruiting - verified March 2015

CVI Drug Coated Balloon First In Human Trial

Condition:   Peripheral Arterial Disease
Intervention:   Device: Percutaneous Transluminal Angioplasty
Sponsor:   Spectranetics Corporation
Completed - verified February 2015

Sarpogrelate Drug Interaction

Conditions:   Hypertension;   Peripheral Artery Disease
Interventions:   Drug: Sarpogrelate pretreatment;   Drug: Sarpogrelate;   Drug: Metoprolol
Sponsor:   Ajou University School of Medicine
Completed - verified February 2015

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

Conditions:   Aortic Valve Disease;   Coronary Artery Disease (CAD)
Interventions:   Drug: Custodiol-N;   Drug: Custodiol
Sponsor:   Dr. F. Köhler Chemie GmbH
Recruiting - verified February 2015

CO2 as a Stress Agent for Perfusion Imaging

Condition:   Coronary Artery Disease
Interventions:   Device: Delivery of precise levels of carbon dioxide with the RespirAct™ Gen4 sequential gas delivery system;   Device: Delivery of rubidium radioisotope (Rb-82) using the automated pump/elution system
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified February 2015

Effects Vitamin D Suppletion on Postprandial Leukocyte Activation

Conditions:   Atherosclerosis;   Oxidative Stress;   Leukocyte Activation Disorder
Interventions:   Drug: Cholecalciferol;   Drug: Cholecalciferol
Sponsor:   Sint Franciscus Gasthuis
Recruiting - verified February 2015

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Condition:   Hyperlipidemia
Interventions:   Drug: Bococizumab (PF-04950615; RN316);   Other: Placebo
Sponsor:   Pfizer
Recruiting - verified February 2015

A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia

Condition:   Heterozygous Familial Hypercholesterolemia
Interventions:   Drug: Bococizumab (PF-04950615;RN316);   Other: Placebo
Sponsor:   Pfizer
Recruiting - verified February 2015

The PzF Shield Trial

Condition:   Coronary Artery Disease
Intervention:   Device: COBRA PzF
Sponsor:   CeloNova BioSciences, Inc.
Active, not recruiting - verified February 2015

Resolute Integrity US Extended Length Sub-Study(RI-US XL)

Condition:   Coronary Artery Disease
Intervention:   Device: Resolute Integrity Stent
Sponsor:   Medtronic Vascular
Recruiting - verified March 2015

A Web-based Approach to Treating Cardiovascular Disease Risk in Employees With Metabolic Syndrome

Conditions:   Metabolic Syndrome;   Cardiovascular Disease;   Atherosclerosis;   Obesity
Intervention:   Behavioral: My Everyday Health
Sponsor:   Baptist Health South Florida
Completed - verified February 2015

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Conditions:   Heart Failure;   Coronary Artery Disease
Interventions:   Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified February 2015

AcoArt I: Effectiveness and Safety Study of Drug Eluting Balloon(DEB) in Percutaneous Transluminal Angioplasty(PTA) Procedure

Condition:   Peripheral Artery Disease
Interventions:   Device: drug eluting balloon catheter (trade name: Orchid);   Device: common percutaneous transluminal angioplasty balloon catheter (trade name: Admiral)
Sponsor:   Acotec Scientific Co., Ltd
Active, not recruiting - verified December 2014

Propofol Effects on Mitral Valve Annular Velocity

Conditions:   Valvular Heart Disease;   Coronary Artery Disease
Intervention:   Drug: propofol
Sponsor:   Konkuk University Medical Center
Recruiting - verified March 2015

Effect of Paricalcitol Over Vessel Wall

Condition:   Nephropathy
Intervention:   Drug: Paricalcitol
Sponsors:   Effice Servicios Para la Investigacion S.L.;   Fundació Renal Jaume Arnó
Terminated - verified February 2015

Neurological Complications Comparing Endoscopically vs. Open Harvest of the Radial Artery

Conditions:   Complications Due to Coronary Artery Bypass Graft;   Coronary Artery Disease;   Myocardial Ischemia;   Coronary Disease;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Interventions:   Procedure: Endoscopic radial artery harvest;   Procedure: Open radial artery harvest;   Procedure: Mammarioradial graft (Y-graft);   Procedure: Aortoradial graft (Free RA)
Sponsor:   Rigshospitalet, Denmark
Recruiting - verified February 2015

Ticagrelor vs Clopidogrel Effect on MFR in CAD Population

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   Ottawa Heart Institute Research Corporation
Active, not recruiting - verified March 2015

Extension Study for 2993-112

Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: AC2993
Sponsor:   AstraZeneca
Completed - verified January 2015

Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin

Condition:   Coronary Artery Disease
Interventions:   Drug: Closone;   Drug: Plavix with Astrix
Sponsor:   Seoul St. Mary's Hospital
Completed - verified February 2015

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

Conditions:   Chronic Total Occlusion of Coronary Artery;   Coronary Occlusion;   Coronary Artery Disease;   Coronary Artery Restenosis;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Restenosis
Intervention:   Device: Absorb Bioresorbable Vascular Scaffold
Sponsor:   Abbott Vascular
Active, not recruiting - verified February 2015

DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)

Condition:   Ischemic Heart Disease
Interventions:   Device: Angio-guided PCI with EES  or BES;   Device: OCT-guided PCI with EES  or BES;   Device: PCI with BES under angio-guide or OCT guide;   Device: PCI with EES under angio-guide or OCT guide;   Drug: Keep DAPT;   Drug: Discontinue DAPT
Sponsor:   Yonsei University
Recruiting - verified February 2015

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: aleglitazar;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Drug Eluting Balloon (DEB) and Long Lesions of Superficial Femoral Artery (SFA) Ischemic Vascular Disease

Condition:   Peripheral Artery Disease
Intervention:  
Sponsor:   Ettore Sansavini Health Science Foundation
Active, not recruiting - verified February 2015

Tryptase and Coronary Heart Disease

Conditions:   Acute Coronary Syndrome With ST Elevation on Electrocardiogram;   Acute Coronary Syndrome Without ST Elevation on Electrocardiogram;   Noncritical Coronary Artery Disease With Coronary Stenosis <50%;   Aortic Aneurysms
Intervention:  
Sponsor:   Niguarda Hospital
Recruiting - verified February 2015

Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Rosuvastatin
Sponsors:   Leiden University Medical Center;   Netherlands Heart Foundation
Recruiting - verified February 2015

Radial Artery Access With Ultrasound Trial

Condition:   Coronary Artery Disease
Interventions:   Procedure: Ultrasound guidance;   Procedure: Palpation
Sponsors:   University of California, Irvine;   Lenox Hill Hospital;   Jamaica Hospital Medical Center;   Oklahoma City VA Medical Center
Completed - verified February 2015

A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Condition:   Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions:   Other: Background care;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease

Condition:   Diabetic Nephropathy
Intervention:  
Sponsors:   Aristotle University Of Thessaloniki;   AHEPA University Hospital
Recruiting - verified February 2015

Iloprost Therapy in Patients With Critical Limb Ischemia

Condition:   Peripheral Arterial Disease
Intervention:   Drug: Iloprost (Ilomedin, BAYQ6256)
Sponsor:   Bayer
Completed - verified February 2015

Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)

Condition:   Cholesterol Embolism Systemic
Interventions:   Drug: prednisone;   Other: placebo
Sponsors:   University Hospital, Toulouse;   Ministry of Health, France
Recruiting - verified February 2015

Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

Condition:   Coronary Artery Disease (CAD)
Interventions:   Procedure: LIMA-LAD surgical revascularization;   Procedure: PCI
Sponsor:   Ettore Sansavini Health Science Foundation
Recruiting - verified February 2015

VISIBILITY™ Iliac Study

Conditions:   Peripheral Arterial Disease;   Claudication
Intervention:   Device: Visi-Pro™ Balloon Expandable Stent System
Sponsor:   Covidien
Active, not recruiting - verified March 2015

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up

Conditions:   Diabetes Mellitus;   Hypertension;   Ischemic Heart Disease;   Stroke
Intervention:  
Sponsor:   Oslo University Hospital
Active, not recruiting - verified February 2015

Management of New-Onset Postoperative Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Coronary Artery Disease;   Post Operative Arrythmia
Intervention:  
Sponsors:   Emory University;   Medtronic
Recruiting - verified February 2015

Resolute Zotarolimus-Eluting Stent Versus the Taxus Liberte Paclitaxel-Eluting Stent for Percutaneous Coronary Intervention in China

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Interventions:   Device: Taxus Liberte Paclitaxel-Eluting Coronary Stent System;   Device: Resolute Zotarolimus-Eluting Coronary Stent System
Sponsor:   Medtronic Vascular
Active, not recruiting - verified March 2015

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Condition:   Coronary Heart Disease
Interventions:   Drug: dalcetrapib;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in China

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention:  
Sponsor:   Medtronic Vascular
Active, not recruiting - verified March 2015

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Condition:   Coronary Heart Disease, Graft Occlusion, Vascular
Interventions:   Drug: Placebo;   Drug: RO4905417
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Cohort of Young Adults Infected With HIV Since Birth or During Childhood

Conditions:   HIV Infection;   Young Adult
Intervention:   Biological: blood sampling, specific biological exams and biobank and self administered questionnaires
Sponsor:   French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified February 2015

Imaging and Biomarkers of Atherosclerosis in Patients With Stable or Unstable Coronary Artery Disease

Conditions:   Atherosclerosis;   Coronary Artery Disease;   Acute Coronary Syndrome
Interventions:   Device: Coronary intervention using IVUS-VH & FDG PET-MDCT;   Device: Coronary intervention using IVUS-VH & FDG PET-MDCT
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Institut National de la Santé Et de la Recherche Médicale, France
Completed - verified February 2015

Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study.

Conditions:   Atrial Fibrillation;   Peripheral Vascular Disease
Intervention:  
Sponsor:   University of Roma La Sapienza
Completed - verified February 2015

Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Volcano Corporation
Completed - verified January 2015

Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol

Condition:   Cardiovascular Disease
Interventions:   Other: Placebo;   Drug: Alpha-CD
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified November 2014

Physiopathology of Rapid Aspirin Desensitization

Conditions:   Hypersensitivity;   Coronary Artery Disease
Intervention:  
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed - verified February 2015

Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE

Condition:   Ischemic Heart Disease
Intervention:   Other: cell therapy
Sponsors:   Medical University of Vienna;   Nantes University Hospital;   Oslo University Hospital;   Medical University of Silesia;   Hannover Medical School;   Cardiovascular Research Center, Aalst, Belgium;   Cedars-Sinai Medical Center;   Johann Wolfgang Goethe University Hospitals;   University of Ulm;   Military Medical Academy, Belgrade, Serbia;   Novosibirsk Scientific Research Institute for Circulatory Pathology;   Rigshospitalet, Denmark;   Asklepios Kliniken Hamburg GmbH;   Leiden University Medical Center;   University of Debrecen;   University of Targu Mures, Romania;   University Clinic for Cardiology, Skopje, Republic of Macedonia;   State Health Center, Hungary;   Karolinska Institutet;   University of Zurich;   University of Oulu;   Odense University Hospital;   Minneapolis Heart Institute;   The University of Texas Health Science Center, Houston;   Klinik Hirslanden, Zurich;   University Hospital, Toulouse;   Heinrich-Heine University, Duesseldorf
Recruiting - verified March 2015

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Conditions:   Critical Limb Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease
Interventions:   Device: Bone marrow concentration device;   Procedure: Placebo procedure (sham)
Sponsor:   Biomet Biologics, LLC
Recruiting - verified July 2014

Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients With Prior Equivocal Stress Test for Detection of Coronary Artery Disease

Conditions:   Myocardial Ischemia;   Coronary Artery Disease;   Myocardial Infarction
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2015

Cardiovascular Disease Study

Condition:   Spinal Cord Injury
Interventions:   Procedure: 2 hour Oral Glucose Tolerance Test;   Procedure: Fat Meal Test
Sponsors:   Department of Veterans Affairs;   Kessler Foundation
Recruiting - verified February 2015

A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Condition:   Peripheral Arterial Disease (PAD)
Interventions:   Drug: RO4905417;   Drug: RO4905417;   Drug: RO4905417;   Drug: placebo;   Drug: placebo;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Condition:   Coronary Heart Disease
Interventions:   Drug: Evidence-based medical care for Acute Coronary Syndrome;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])

Conditions:   Coronary Disease;   Cardiovascular Diseases
Intervention:  
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified February 2015

Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique

Condition:   Coronary Arteriosclerosis
Intervention:   Device: OFDI  system
Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2015

Database Registry of the Intermountain Heart Collaborative Study

Conditions:   Coronary Artery Disease;   Electrophysiology;   Cardiovascular Disease
Intervention:  
Sponsor:   Intermountain Health Care, Inc.
Recruiting - verified February 2015

A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Non-Insulin-Dependent
Interventions:   Drug: AC2993;   Drug: AC2993;   Drug: Placebo;   Drug: Placebo
Sponsor:   AstraZeneca
Completed - verified January 2015

Get CardioSmart

You're Invited